Pulmonary surfactant replacement

This page covers all Pulmonary surfactant replacement drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Pulmonary surfactant (lipid and protein complex), Pulmonary surfactant (phospholipid and protein complex), Pulmonary surfactant (lipid-protein complex).

Targets

Pulmonary surfactant (lipid and protein complex) · Pulmonary surfactant (phospholipid and protein complex) · Pulmonary surfactant (lipid-protein complex)

Marketed (1)

• Poractant alfa instillation · Poznan University of Medical Sciences · Respiratory/Pulmonology
  Poractant alfa is a natural pulmonary surfactant that replaces deficient or dysfunctional surfactant in the lungs to restore normal respiratory function.

Phase 3 pipeline (2)

• Curosurf-Group1 · Ottawa Hospital Research Institute · Respiratory/Neonatology
  Curosurf is a natural pulmonary surfactant that replaces deficient surfactant in the lungs to improve gas exchange and reduce surface tension in the alveoli.
• Aerosolized Calfactant · ONY · Respiratory/Pulmonology
  Aerosolized calfactant is a pulmonary surfactant replacement therapy delivered directly to the lungs via inhalation to restore surfactant function and improve gas exchange.